Using Immunomagnetic Reduction to Assay Reagent Stability of Biomarkers Associated with Alzheimer's Disease

Using Immunomagnetic Reduction to Assay Reagent Stability of Biomarkers Associated with Alzheimer's Disease - Liu et al. 2021

Using Immunomagnetic Reduction to Assay Reagent Stability of Biomarkers Associated with Alzheimer's Disease

© 2021 Liu, Lin, Chen, Hu, Ho and Yang

Journal of Neurological Disorders

Previous
Previous

Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer’s Disease but Not in Parkinson’s Disease or Frontotemporal Dementia

Next
Next

Neurofilament light chain level in plasma extracellular vesicles and Parkinson’s disease